#AZN
-

AstraZeneca Shares Drop 5.7% After Wainua Phase 3 Trial Miss
AstraZeneca lost about $24 billion in market value after Wainua failed a pivotal Phase 3 heart trial. Investors are now…

AstraZeneca lost about $24 billion in market value after Wainua failed a pivotal Phase 3 heart trial. Investors are now…